The Global Beta-Glucan Market was valued at USD 542 million in 2024 and is projected to reach USD 864.88 million by 2030, expanding at a CAGR of 8.1% during the forecast period (2025–2030). Rising consumer awareness of immune health, cardiovascular wellness, and preventive healthcare is positioning beta-glucans as a high-value functional ingredient across pharmaceuticals, nutraceuticals, food & beverages, and personal care.
REQUESTSAMPLE:https://virtuemarketresearch.com/report/beta-glucan-market/request-sample
Market Overview
Beta-glucans are naturally occurring polysaccharides found in cereals (such as oats and barley), yeast, mushrooms, bacteria, and fungi. Known for their immune-modulating, cholesterol-lowering, blood sugar-regulating, and gut health-supporting properties, they have become a cornerstone ingredient in modern health and wellness formulations.
The post-pandemic emphasis on preventive healthcare has accelerated demand for ingredients that support immunity and overall wellness. As consumers shift toward clean-label and plant-based solutions, beta-glucans are increasingly incorporated into dietary supplements, fortified foods, beverages, and skincare products.
Key Market Insights
Oat-derived beta-glucans accounted for 45% of total market revenue in 2023.
Yeast-derived beta-glucans recorded a 13% year-over-year increase in demand.
Pharmaceutical applications contributed USD 148 million to the market.
Over 68% of functional foods launched in 2023 contained beta-glucans.
Beta-glucan-based dietary supplements represented 25% of overall market volume.
Europe accounted for 40% of global beta-glucan production.
Beta-glucans were included in 15% of immune-support product launches globally.
Key Market Drivers
1. Rising Consumer Awareness of Immune Health
One of the strongest drivers of the beta-glucan market is the global focus on immune health. Following the COVID-19 pandemic, consumers increasingly prioritize ingredients that strengthen natural defenses.
Beta-glucans activate macrophages and other immune cells, helping the body combat infections and environmental stressors. This immunomodulatory property has driven their widespread adoption in dietary supplements and functional foods.
The elderly population—more vulnerable to immune-related conditions—is a key target demographic. Manufacturers are actively incorporating beta-glucans into immune-support capsules, powders, and fortified beverages.
The growth of e-commerce platforms such as Amazon has further expanded product accessibility, boosting global demand.
2. Surge in Lifestyle-Related Diseases
The global rise in chronic diseases—such as cardiovascular disorders, diabetes, and obesity—has significantly increased demand for functional ingredients like beta-glucans.
Cardiovascular Health
Beta-glucans are recognized for their cholesterol-lowering properties. They form a viscous gel in the digestive tract that binds bile acids, reducing LDL cholesterol levels. Regulatory bodies such as the U.S. Food and Drug Administration and the European Food Safety Authority have acknowledged the role of oat beta-glucans in supporting heart health.
This endorsement has strengthened their presence in heart-health cereals, bakery products, and dietary supplements.
Blood Sugar Regulation
Beta-glucans slow glucose absorption, helping regulate blood sugar levels—an important benefit amid rising global diabetes prevalence.
Gut Health Support
As prebiotics, beta-glucans promote the growth of beneficial gut bacteria, enhancing digestive health and overall immunity. The growing recognition of the gut–immune connection has further expanded their applications in functional foods and nutraceuticals.
Market Restraints and Challenges
Despite strong growth prospects, several challenges persist:
High Production Costs
The extraction and purification of high-quality beta-glucans—especially pharmaceutical-grade variants—require advanced processing technologies, increasing production costs.
Regulatory Complexity
Different regions impose varying labeling and health claim regulations, complicating global expansion.
Competition from Alternative Ingredients
Ingredients such as probiotics and omega-3 fatty acids have higher consumer awareness, creating competitive pressure in the functional health market.
Limited Awareness in Developing Regions
Although awareness is growing, developing markets still present education challenges regarding the health benefits of beta-glucans.
Market Opportunities
1. Personalized Nutrition
The shift toward personalized health solutions presents a major opportunity. Beta-glucans can be incorporated into customized dietary programs targeting immunity, cholesterol control, or metabolic health.
2. Pet Nutrition
Premium pet food manufacturers are incorporating beta-glucans into formulations to enhance immune support for companion animals, opening a promising niche segment.
3. Sustainable Production Innovations
Advances in biotechnology and fermentation processes can reduce extraction costs and environmental impact, improving scalability and accessibility.
4. Advanced Therapeutic Applications
Ongoing research exploring beta-glucans in cancer immunotherapy and advanced dermatological formulations could unlock high-value pharmaceutical opportunities.
Market Segmentation
By Type
Oat-derived Beta-Glucans (Dominant Segment)
Yeast-derived Beta-Glucans (Fastest Growing)
Barley-derived Beta-Glucans
Mushroom-derived Beta-Glucans
Oat-derived variants dominate due to well-established cardiovascular benefits and extensive use in functional foods. Yeast-derived beta-glucans are expanding rapidly because of their superior immunomodulatory effects in pharmaceutical applications.
By Distribution Channel
Supermarkets and Hypermarkets (Largest Share)
Specialty Stores
Online Retail (Fastest Growing)
Pharmacies and Drugstores
The rise of online retail has significantly accelerated growth, particularly for dietary supplements and specialty health products.
BUYNOW:https://virtuemarketresearch.com/report/beta-glucan-market/enquire
Regional Analysis
Europe (Market Leader)
Europe leads the beta-glucan market, supported by high consumer awareness, strong functional food demand, and favorable regulatory backing for health claims.
Asia-Pacific (Fastest Growing)
Asia-Pacific is witnessing rapid expansion due to increasing health consciousness, rising disposable incomes, and a growing nutraceuticals sector.
North America
North America remains a strong contributor, driven by innovation in dietary supplements and fortified foods.
Latin America & Middle East & Africa
These regions present emerging opportunities fueled by improving healthcare awareness and expanding retail infrastructure.
COVID-19 Impact
The COVID-19 pandemic significantly amplified demand for immune-support ingredients. Beta-glucan sales surged in supplements and fortified food categories as consumers sought preventive solutions.
However, supply chain disruptions increased production costs and caused logistical delays. The long-term impact has been positive, as immunity remains a top consumer priority.
Latest Trends and Developments
Rise of personalized nutrition formulations
Increased integration into plant-based and vegan products
Advancements in extraction technologies for higher purity
Sustainable sourcing and eco-friendly production
Encapsulation and enhanced delivery systems for improved bioavailability
Manufacturers are focusing on innovation to enhance functionality and consumer convenience.
Competitive Landscape
Key players shaping the global beta-glucan market include:
Cargill, Incorporated
Kerry Group plc
Koninklijke DSM N.V.
Tate & Lyle PLC
Lesaffre
Associated British Foods plc
Angel Yeast Co., Ltd.
These companies focus on product innovation, strategic collaborations, and sustainable production practices to strengthen market positioning.
CUSTOMISATION: https://virtuemarketresearch.com/report/beta-glucan-market/customization
Conclusion
The global beta-glucan market is on a strong growth trajectory, driven by rising immune health awareness, increasing chronic disease prevalence, and expanding applications in functional foods and nutraceuticals. While production costs and regulatory complexities pose challenges, opportunities in personalized nutrition, sustainable production, and advanced therapeutic applications offer significant long-term potential.